Methamphetamine compromises gap junctional communication in astrocytes and neurons

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Methamphetamine (meth) is a potent central nervous system (CNS) stimulant causing dependency.
• Long-term meth use leads to CNS issues like altered neuronal plasticity, blood-brain barrier compromise, and inflammation.
• Meth's CNS effects are linked to neurotransmitter dysregulation, but its impact on connexin channels is unclear.

Purpose of the Study:

• To investigate methamphetamine's effects on connexin (Cx) expression and function.
• To determine the role of Cx channels in methamphetamine-induced neurotoxicity and NeuroAIDS.

Main Methods:

• Examined Cx expression and localization following meth treatment.
• Assessed gap junction (GJ) communication and hemichannel (HC) activity in neurons and astrocytes.
• Investigated the role of dopamine receptors in meth-induced Cx channel changes.
• Evaluated the impact of these changes on glutamate metabolism and neuronal/glial apoptosis in the context of HIV.

Main Results:

• Methamphetamine altered Cx expression and localization.
• Meth reduced GJ communication and induced Cx43/Cx36 HC opening, mediated by dopamine receptor activation.
• These Cx channel alterations amplified CNS toxicity by disrupting glutamate metabolism.
• Meth-induced changes increased neuronal and astrocyte susceptibility to HIV-induced bystander apoptosis.

Conclusions:

• Connexin channels (GJ and HC) are critical in methamphetamine pathogenesis.
• Methamphetamine disrupts CNS function by compromising Cx channels, increasing vulnerability to HIV-related neurological disease.
• Dopamine signaling dysregulation is key to meth-induced GJ and HC dysfunction.